220 related articles for article (PubMed ID: 30608261)
1. Frequent TLE1 Expression in Cutaneous Neoplasms.
Xiong Y; Dresser K; Cornejo KM
Am J Dermatopathol; 2019 Jan; 41(1):1-6. PubMed ID: 30608261
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
3. TdT expression in normal and neoplastic sebaceous cells.
Tzorakoleftheraki SE; Iliadis A; Kostopoulos I; Koletsa T
Histopathology; 2017 Dec; 71(6):985-988. PubMed ID: 28677299
[TBL] [Abstract][Full Text] [Related]
4. Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Wada J; Urabe S; Hirano T; Kawano K; Suzuki M; Yokoyama S; Daa T
Diagn Pathol; 2018 Jul; 13(1):48. PubMed ID: 30053869
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma.
Murata T; Nakashima Y; Takeuchi M; Sueishi K; Inomata H
Pathol Res Pract; 1993 Sep; 189(8):888-93. PubMed ID: 7508102
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD10 in basal cell carcinoma.
Yada K; Kashima K; Daa T; Kitano S; Fujiwara S; Yokoyama S
Am J Dermatopathol; 2004 Dec; 26(6):463-71. PubMed ID: 15618927
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
Milman T; Schear MJ; Eagle RC
Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.
Clark LN; Elwood HR; Uhlenhake EE; Smoller BR; Shalin SC; Gardner JM
J Cutan Pathol; 2016 Aug; 43(8):657-62. PubMed ID: 27153463
[TBL] [Abstract][Full Text] [Related]
9. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall.
Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM
Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396
[TBL] [Abstract][Full Text] [Related]
10. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
11. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
Heyl J; Mehregan D
J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
[TBL] [Abstract][Full Text] [Related]
12. PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.
Ng JKM; Choi PCL; Chow C; Li JJX; Chan AWS; Cheung CMT; Ip ECC; Ng HK; To KF
Pathology; 2022 Oct; 54(6):721-728. PubMed ID: 35644638
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.
Uhlenhake EE; Clark LN; Smoller BR; Shalin SC; Gardner JM
J Cutan Pathol; 2016 Aug; 43(8):649-56. PubMed ID: 27153339
[TBL] [Abstract][Full Text] [Related]
14. TERT promoter mutation in sebaceous neoplasms.
Muñoz-Jiménez MT; Blanco L; Ruano Y; Carrillo R; Santos-Briz Á; Riveiro-Falkenbach E; Requena L; Kutzner H; Garrido MC; Rodríguez-Peralto JL
Virchows Arch; 2021 Sep; 479(3):551-558. PubMed ID: 33768319
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
Seleit I; Bakry OA; Samaka RM; Malak MA
Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation.
Bayer-Garner IB; Givens V; Smoller B
Am J Dermatopathol; 1999 Oct; 21(5):426-31. PubMed ID: 10535570
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid-Like/Labyrinthine Pattern in Sebaceous Neoplasms Represents a Sebaceous Mantle Phenotype: Immunohistochemical Analysis of Aberrant Vimentin Expression and Cytokeratin 20-Positive Merkel Cell Distribution.
Goto K; Anan T; Fukumoto T; Kimura T; Misago N
Am J Dermatopathol; 2017 Nov; 39(11):803-810. PubMed ID: 28027080
[TBL] [Abstract][Full Text] [Related]
18. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
Chen WS; Chen PL; Li J; Lind AC; Lu D
J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
[TBL] [Abstract][Full Text] [Related]
19. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
20. Follicular squamous cell carcinoma of the skin: a poorly recognized neoplasm arising from the wall of hair follicles.
Diaz-Cascajo C; Borghi S; Weyers W; Bastida-Inarrea J
J Cutan Pathol; 2004 Jan; 31(1):19-25. PubMed ID: 14675281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
